MedPath

a comparative clinical study of erandbeejadi gutika pippalyadi gana kashaya and ruksha pottali sweda in the management of amavata

Phase 1
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Registration Number
CTRI/2023/02/049968
Lead Sponsor
Department of Kayachikitsa Shri Narayan Prasad Awasthi Govt. Ayurved College Raipur CHHATTISGARH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

it is based on Clinical signs and symptoms mentioned in ayurvedic and modern classics, especially pain swelling, and stiffness.

Health Assessment Questionnaire for RA

Visual Analog Scale (VAS)

WOMAC Index

Exclusion Criteria

1.Patients below 18 years and above 60 years of age will not be taken.

2.Patients who develop a secondary complication of RA e.g. pleuro-pericardial disease. severely damaged joint with bedridden patients and severe crippling deformities.

3.Patients having neoplasm of the spine, gout, ankylosing spondylitis, traumatic arthritis, and pyogenic osteomyelitis.

4.Patients suffering from paralysis, Liver cirrhosis, Liver failure, Hepatocellular or any carcinoma, and Ascites.

5.Patients having associated cardiac disease, pulmonary tuberculosis, uncontrolled diabetes mellitus, malignant hypertension, renal function impairment, etc.

6.Pregnant and lactating mother.

7.Patients who are taken steroids.

8.Other joint disorders like Gout, Osteoarthritis.

The patient mentioned above who is suffering from any severe disease will come under the category of exclusion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduce the symptoms of amavata especially pain,swelling and stiffness(rheumatoid arthritis)Timepoint: reduce the symptoms of amavata in 8 weeks
Secondary Outcome Measures
NameTimeMethod
improve the quality of lifeTimepoint: 90 days
Âİ Copyright 2025. All Rights Reserved by MedPath